Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc in immunological non-responder HIV-1-infected patients
2008-002661-30Phase 4Completed
- Sponsor
- Luigi Sacco University Hospital
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of maraviroc in human immunodeficiency virus infection (HIV), sponsored by Luigi Sacco University Hospital. Primary endpoints: Immunologic response at 3 months and Immunologic response at 12 months. Started Jun 2008; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2008-002661-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002661-30.